Charles Schwab Investment Advisory’s Humana HUM Stock Holding History

Charles Schwab Investment Advisory’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-579	Closed	-$265K	–	126
2023 Q4	$265K	Sell	579 -78	-12%	-$38.4K	﹤0.01%	92
2023 Q3	$320K	Buy	657 +79	+14%	+$37.1K	﹤0.01%	76
2023 Q2	$258K	Hold	578	–	–	﹤0.01%	94
2023 Q1	$281K	Sell	578 -2	-0.3%	-$989	﹤0.01%	89
2022 Q4	$297K	Buy	580 +1	+0.2%	+$526	﹤0.01%	82
2022 Q3	$281K	Hold	579	–	–	﹤0.01%	89
2022 Q2	$271K	Buy	579 +3	+0.5%	+$1.33K	﹤0.01%	83
2022 Q1	$251K	Hold	576	–	–	﹤0.01%	92
2021 Q4	$267K	Hold	576	–	–	﹤0.01%	83
2021 Q3	$224K	Hold	576	–	–	﹤0.01%	82
2021 Q2	$255K	Sell	576 -4	-0.7%	-$1.75K	﹤0.01%	81
2021 Q1	$243K	Hold	580	–	–	﹤0.01%	80
2020 Q4	$238K	Buy	580 +4	+0.7%	+$1.66K	﹤0.01%	67
2020 Q3	$238K	Hold	576	–	–	﹤0.01%	62
2020 Q2	$223K	Buy	+576	New	+$216K	﹤0.01%	63

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Charles Schwab Investment Advisory's HUM Position: Q1 2024 in Review

Charles Schwab Investment Advisory sold out of Humana (HUM) in Q1 2024, closing a stake of 579 shares — an estimated $265K sold.

Charles Schwab Investment Advisory first reported a position in HUM in Q2 2020 and held it in 15 quarters. The position peaked at $320K in Q3 2023. 1,030 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

Charles Schwab Investment Advisory reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
Charles Schwab Investment Advisory sold 579 Humana shares in Q1 2024, an estimated $265K.
Charles Schwab Investment Advisory first reported a position in Humana in Q2 2020 and held it in 15 quarters.
Charles Schwab Investment Advisory's Humana position peaked at $320K in Q3 2023.
1,030 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Charles Schwab Investment Advisory's 13F filing for Q1 2024, filed 9 May 2024.